← Dashboard
Nov 11, 2026 12:47 PM ET
Signal
Corporate
MiNK Therapeutics GAAP EPS of -$0.50 beats by $0.16, revenue of $0.2M beats by $0.13M
GAAP EPS beat by $0.16 and revenue beat by $0.13M.
What changed
GAAP EPS beat by $0.16 and revenue beat by $0.13M.
Why it matters
GAAP EPS beat by $0.16 and revenue beat by $0.13M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →